Consequently, an efficient TB vaccine should be able to induce the formation of antigen-specific polyfunctional type-1 CD4 + and CD8+ T cells through peptides presented by MHC-II and MHC-I, respectively, on the surface of infected macrophages (9, 10). Here, CD4 is linked to tuberculosis.